 |
 |
|
miércoles, 03 abril 2013 |
IBB researchers
unveil new details on the mechanism of regulation of cellular division and
publish the first structure with data acquired at the ALBA Synchrotron
Protein
phosphorylation is one of the most important mechanisms involved in the
regulation of protein-protein interactions and thus takes part in many cellular
signaling pathways such as the formation and separation of mitotic spindles
during cellular division. There is a family of protein kinases called NEKs
which take part in the control of the machinery involved in the mitotic spindle
microtubule formation. NEK9, along with NEK6 and NEK7, form a signaling cascade
which is essential for mitotic progression, as it controls the formation of the
mitotic spindle and the organization of centrosomes. These mechanisms must be
perfectly regulated to avoid mistakes which might result in pathologies
associated to cellular division, such as cancer. The research group on Protein
Structure, at the Institut de Biotecnologia i de Biomedicina (IBB) in the Universitat
Autònoma of Barcelona, lead by David Reverter, has analyzed the regulation of the NEK9 kinase, which can be
activated or deactivated depending on its interaction with LC8 – the regulator
protein. Such regulation depends on the phosphorylation of a residue found at
the interphase between the two proteins. Using protein crystallography, a
technique used in structural biology which allows us to see protein and big
molecular complexes at an atomic level, IBB researchers have shown how phosphorylation
is enough to regulate the interaction between these two proteins: kinase NEK9 and the regulator protein
LC8. Their results shed a light on the complex regulation pathway for cell
division, valuable information when it comes to finding new therapeutic
strategies for complex diseases such as cancer.
The
work, published in JBC, is the first with a 3D structure done with data
obtained in the BL13-XALOC beam line of the ALBA Synchrotron, and the result of
a collaboration between the IBB group with researchers from the IRB Barcelona
and the Institute for Biocomputation and Physics of Complex Systems at the
Zaragoza University.
The figure shows crystal structures of the LC8 regulatory protein with two
peptides from kinase NEK9: on the right, the interactions with a phosphorylated
peptide and on the left, with a non-phosphorylated peptide. Taken from fig.2 at Gallego et al., 2013. Structural analysis of the regulation of the
DYNLL/LC8 binding to Nek9 by phosphorylation.
Interesting links:
Sincrotrón ALBA http://www.cells.es
IRB Barcelona http://www.irbbarcelona.org/index.php/en
|
|
jueves, 31 enero 2013 |
|
IBB researcher, Aurora Ruiz-Herrera, from the
Cytogenetics laboratory, and member of the Department of Cellular Biology,
Physiology and Immunology at the Universitat Autònoma de Barcelona, has been
recently awarded a grant from the Barcelona Zoo Foundation to carry out a
collaborative research project with the main objective of creating and
cryopreserving cell lines from different mammalian species available at the zoo
collection.
Currently there are very few centers worldwide
with the capacity of keeping alive genetic material from species in risk of
extinction, and none of them, till now, in Spain. The cell lines generated within the project
will be available to the scientific community and will offer an invaluable
material to help understand the current biodiversity in animal species,
necessary to formulate conservational studies / programmes – and useful when it
comes to understand the biology, genetics and evolution of different animal
species.
The methodology used to develop these cell
lines is the result of years of work at the UAB and will provide with an easily
accessible source of safe genetic material.
Direct applications of the cell lines are diverse and can include
research projects in conservation, or genomic and/or proteomic studies, among
others.
Photo's author: Dra. Aurora Ruiz-Herrera
|
|
sábado, 24 marzo 2012 |
|
Researchers of the group of Applied Microbiology of IBB, led by Prof. Antoni Villaverde, have created nanoparticles which could release drugs directly from the cells' interior. The technology, which has been named “nanopills”, was licensed to the firm Janus Developments of the Barcelona Scientific Park, which verified its tolerance by administering it in vivo. The results have been published in the journal Advanced Materials.
See the complete press note
Accés a l'article de recerca
|
|
|
 |
|